NHS to offer women in England drug that cuts recurrence of breast cancer

NHS to offer women in England drug that cuts recurrence of breast cancer Thousands of women in England with breast cancer are to benefit from a new pill on the NHS which reduces the risk of the disease coming back.

The National Institute for Health and Care Excellence (Nice) has given the green light to abemaciclib, which cuts the chance of breast cancer returning after a patient has had surgery to remove a tumour. The Guardian

See also:

• NICE recommends step-change targeted treatment for people with early breast cancer National Institute for Health and Care Excellence